Inhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivo
about
Personalized medicine in gastric cancer: Where are we and where are we going?Molecular classification of gastric cancer: Towards a pathway-driven targeted therapyRETRACTED: Role of microRNA 30a targeting insulin receptor substrate 2 in colorectal tumorigenesis.Evaluation of selected interleukins in patients with different gastric neoplasms: a preliminary report.Elevated GRP78 expression is associated with poor prognosis in patients with pancreatic cancerSingle agent BMS-911543 Jak2 inhibitor has distinct inhibitory effects on STAT5 signaling in genetically engineered mice with pancreatic cancerA novel small molecule STAT3 inhibitor, LY5, inhibits cell viability, colony formation, and migration of colon and liver cancer cells.Associations of potentially functional variants in IL-6, JAKs and STAT3 with gastric cancer risk in an eastern Chinese population.Mitochondrial GRIM-19 as a potential therapeutic target for STAT3-dependent carcinogenesis of gastric cancer.Mouse models for gastric cancer: Matching models to biological questions.Portrait of inflammatory response to ionizing radiation treatment.STAT3: a critical component in the response to Helicobacter pylori infection.Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway.Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy.Novel long non-coding RNA GACAT3 promotes gastric cancer cell proliferation through the IL-6/STAT3 signaling pathway.Role of interleukin-6 in cancer progression and therapeutic resistance.Integrated expression analysis identifies transcription networks in mouse and human gastric neoplasia.NF-κB Signaling in Gastric Cancer.Docosahexaenoic acid inhibits Helicobacter pylori-induced STAT3 phosphorylation through activation of PPARγ.Characterization of the aminopyridine derivative KRC-180 as a JAK2 inhibitor.The conundrum of the Epstein-Barr virus-associated gastric carcinoma in the Americas.MicroRNA-216a inhibits the metastasis of gastric cancer cells by targeting JAK2/STAT3-mediated EMT process.Janus Kinase 2 (JAK2) Dissociates Hepatosteatosis from Hepatocellular Carcinoma in Mice.Kinome and Transcriptome Profiling Reveal Broad and Distinct Activities of Erlotinib, Sunitinib, and Sorafenib in the Mouse Heart and Suggest Cardiotoxicity From Combined Signal Transducer and Activator of Transcription and Epidermal Growth Factor RArsenic trioxide attenuates STAT-3 activity and epithelial-mesenchymal transition through induction of SHP-1 in gastric cancer cells.Delayed Administration of WP1066, an STAT3 Inhibitor, Ameliorates Radiation-Induced Lung Injury in Mice.Prognostic significance of microsatellite instability‑associated pathways and genes in gastric cancer.Ganoderic acid A exerts antitumor activity against MDA-MB-231 human breast cancer cells by inhibiting the Janus kinase 2/signal transducer and activator of transcription 3 signaling pathwayInhibition of STAT3 in gastric cancer: role of pantoprazole as SHP-1 inducerThe Association Between AURKA Gene rs2273535 Polymorphism and Gastric Cancer Risk in a Chinese Population
P2860
Q26774521-4E105AB0-2642-4F47-A633-62E0A4EFEE6CQ26798420-77F092C8-84CD-4364-9BDD-136DD2E407A3Q35097075-EE96970E-C1EB-45D6-A55F-A1F22BB61D24Q36184791-B469F15F-4AF9-4855-9ACB-A7D6D60287BCQ36245668-EDF878F4-E85E-40D9-B685-9CCB8D30E723Q36689024-09E5F930-AA78-48A1-B378-AA7B53A9BDDCQ37022338-E0ED09A9-3D97-4F4F-BA6F-EAA602830FF8Q37317497-91FE4BA8-48D9-4233-9C39-334C8219C9C9Q37520244-2B55686A-18EF-47DF-81F9-D9512C012AD4Q37664258-928228F3-0980-4180-8576-3D8561966EF1Q38364169-2A68D8FA-CCEC-4170-AA32-A449B31D9E54Q38579179-EAA690F7-122E-4105-9613-E414DDD95A52Q38704737-C6A5FA46-CB3B-47FE-9C57-CF362015B86AQ38734014-72833EF5-49E5-4DB1-A560-8C0D222EAD93Q38745185-E9B0862A-A8AF-4F1B-AA0D-532F9C95B4E0Q38853625-3467CE81-1D14-41B8-A970-0FD15B8D615BQ38915431-747FCC45-118E-472D-8BD1-C2EE775AF6A9Q39204794-219C72BE-D702-4CA0-8899-E545A90E3FA4Q40714012-319AB021-196B-4B09-932D-4F0F934A8F65Q41143505-6DC284B3-6337-48F2-AA6F-F8A33184B544Q45325453-77B05E71-A25B-4F1D-8B4A-A1B99D02F2F4Q45994703-B3972D48-7B8B-4FC4-8099-DE07B9427B5AQ46430962-77C4C30F-DB79-4ECD-8079-31D3B996DA05Q47107119-4E48DCEF-5071-43A3-97D9-856778A7FBA3Q49464971-825CFBBF-BD5E-4D9C-BDE7-7EE0C1654822Q53279536-E1FE0938-149B-441A-9483-B3EAFEFA2F22Q54979917-D83FDAFE-893F-4E0A-9CB4-FE747C65804BQ58572515-0B54CB09-F282-418C-8AD0-A401DD8555B1Q58761778-F8F84127-B2A3-4014-BEAE-C0860248ED54Q58769257-89CF9724-96FF-45D6-BC16-8E7CC039DB16
P2860
Inhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivo
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Inhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivo
@ast
Inhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivo
@en
type
label
Inhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivo
@ast
Inhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivo
@en
prefLabel
Inhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivo
@ast
Inhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivo
@en
P2093
P2860
P50
P1433
P1476
Inhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivo
@en
P2093
Anastasia Kalantzis
Andrew S Giraud
Cameron B Jackson
Waldemar Priebe
P2860
P304
P356
10.1371/JOURNAL.PONE.0095993
P407
P577
2014-05-07T00:00:00Z